Vistagen TherapeuticsVTGN

13F holders, Q4 2024 (December 31)
54holders +7
11new positions
8sold out
2famous investors
$2.89avg. 13F price*

At the end of Q4 2024, 54 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings, up 7 from Q3 2024. 11 opened new positions and 8 sold out. The largest holders were TCG Crossover Management, LLC ($7.9M), Vanguard Group Inc. ($6.0M) and Stempoint Capital LP ($5.9M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Vistagen Therapeutics Inc.
CUSIP
92840H400
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2024: 41Q1 2024Q2 2024: 42Q2 2024Q3 2024: 47Q3 2024Q4 2024: 54Q4 2024Q1 2025: 48Q1 2025Q2 2025: 51Q2 2025Q3 2025: 58Q3 2025Q4 2025: 55Q4 2025Q1 2026: 56Q1 2026Q2 2026: 48Q2 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions11$1.6M
Exits8$9.2M

All 13F filers, Q3 2024 → Q4 2024: 2,938,720 shares bought and 3,251,728 shares sold, net −313,008 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 54 holders

TCG Crossover Management, LLC 0.77% No change 2,676,580 $7.9M
Vanguard Group Inc. 0.00% Add +12.7% 2,020,351 $6.0M
Stempoint Capital LP 1.49% Add +26.1% 2,328,492 $5.9M
Nantahala Capital Management, LLC 0.41% Add +30.6% 1,981,980 $5.8M
Commodore Capital LP 0.34% No change 1,575,000 $4.6M
Sphera Funds Management LTD. 0.44% No change 808,550 $2.4M
JPMorgan Chase & Co. 0.00% Add +4826425.0% 772,244 $2.3M
Diadema Partners LP 1.47% — 442,520 $1.3M
BlackRock, Inc. 0.00% Reduce -0.1% 411,553 $1.2M
Geode Capital Management, LLC 0.00% Reduce -0.6% 256,926 $758K
Almitas Capital LLC 0.17% New 254,655 $751K
Goldman Sachs Group Inc. 0.00% Add +10.4% 194,533 $574K
BML Capital Management, LLC 0.27% No change 150,000 $443K
Two Sigma Investments, LP 0.00% Add +123.2% 137,334 $405K
UBS Group AG 0.00% Add +1207.3% 132,314 $390K
ADAR1 Capital Management, LLC 0.08% Reduce -25.5% 121,461 $358K
Persistent Asset Partners Ltd 0.30% — 121,651 $352K
Squarepoint Ops LLC 0.00% Add +290.7% 107,744 $318K
AdvisorShares Investments LLC 0.06% Add +47.3% 99,810 $294K
Blair William & Co. 0.00% Add +11.3% 98,466 $290K
Group One Trading LLC 0.01% New 97,727 $288K
State Street Corp. 0.00% Add +9.2% 96,858 $286K
Susquehanna International Group, LLP 0.00% Add +84.1% 95,906 $283K
Renaissance Technologies 0.00% Reduce -56.1% 83,700 $247K
Ikarian Capital, LLC 0.07% New 77,616 $229K
Northern Trust Corp. 0.00% Reduce -8.5% 45,211 $133K
Landscape Capital Management, L.L.C. 0.01% New 41,804 $123K
Millennium Management 0.00% Add +52.9% 38,732 $114K
American Century Companies Inc. 0.00% Reduce -0.7% 30,002 $89K
Prosperity Wealth Management, Inc. 0.04% New 29,250 $86K
Charles Schwab Investment Management Inc. 0.00% No change 23,302 $69K
Boothbay Fund Management, LLC 0.00% New 22,415 $66K
Bank of America Corp. 0.00% Add +1068.0% 21,141 $62K
HighTower Advisors, LLC 0.00% No change 20,828 $61K
Kestra Advisory Services, LLC 0.00% Add +0.4% 20,116 $59K
Man Group plc 0.00% New 18,338 $54K
Morgan Stanley 0.00% Add +221.3% 17,092 $50K
Two Sigma Advisers, LP 0.00% New 12,032 $35K
Osaic Holdings, Inc. 0.00% Add +11.8% 11,430 $34K
R Squared Ltd 0.02% — 8,610 $25K
Caption Management, LLC 0.00% No change 4,460 $13K
Cwm, LLC 0.00% Add +41.4% 3,416 $10K
Simplex Trading, LLC 0.00% Reduce -88.7% 2,593 $7K
Royal Bank of Canada 0.00% Reduce -58.7% 1,859 $5K
Performa Ltd (US), LLC 0.00% New 1,000 $3K
Bfsg, LLC 0.00% No change 1,000 $3K
MAI Capital Management 0.00% New 609 $2K
BNP Paribas Financial Markets 0.00% New 473 $1K
SBI Securities Co., Ltd. 0.00% — 286 $844
Jones Financial Companies LLLP 0.00% Add +250.0% 280 $826
Tower Research Capital LLC (TRC) 0.00% Reduce -90.1% 223 $658
SJS Investment Consulting Inc. 0.00% No change 100 $295
Fairman Group, LLC 0.00% No change 29 $86
Citigroup Inc. 0.00% Reduce -99.8% 3 $9

"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.